Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents
about
Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women.Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes.Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.Daily variations in ceftriaxone pharmacokinetics in ratsReversing the myths obstructing the determination of optimal age- and disease-based drug dosing in pediatricsInvestigation of bioequivalence and tolerability of intramuscular ceftriaxone injections by using 1% lidocaine, buffered lidocaine, and sterile water diluents.Single-dose ceftriaxone for chancroidSingle-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.Clinical pharmacology of ceftriaxone in patients with neoplastic disease.Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteersComparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women.Validation and Application of a Dried Blood Spot Ceftriaxone Assay.Pharmacokinetics of ceftriaxone.Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.Can Lidocaine be Safely Used to Reduce Pain Caused by Intramuscular Penicillin Injections? A Short Literature Review.Challenges Associated with Route of Administration in Neonatal Drug Delivery.Clinical features and treatment of Lyme disease.The safety and tolerability of the second-line injectable antituberculosis drugs in children.Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.Once-daily ceftriaxone for skin and soft tissue infections.Efficacy and safety of ceftriaxone in serious pediatric infections.Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.Accidental induced seizures in three cynomologus macaques following administration of ceftriaxone dissolved in 1% lidocaine diluent.Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs.Effect of Co-Administration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children with Multidrug-Resistant Tuberculosis: A Randomized Crossover Trial.
P2860
Q33583077-A75E2AC8-708A-42F4-9BF2-A5C2065CEFA2Q33769985-79EBCBA9-6F9B-4E59-A9D0-0284C9835D17Q34621459-A355CA10-6766-4ED4-B6D1-5E70A4BCF547Q34824282-1D3A68B0-6B1E-441D-9178-1385FDC32D21Q35104991-1214C197-9035-4A0F-AF94-9A7CC1E35AA1Q35122616-0DC3410B-F574-4814-989E-EA9A473199A3Q35535586-BCB5F98E-45A9-49D3-8DC1-B5081CF8A03AQ35569544-E541608B-AB12-4E32-B8DE-0397E10C6CDCQ35640044-86F9E9D9-61F9-4B7C-84C3-2F2507DC3B52Q35740465-923B4FB4-50FB-4D51-920A-DB349373EEE7Q35767452-A00DAD46-02ED-470B-9E73-4B247CE616A2Q35769451-B4E0A3B3-95BE-4D75-8CFB-826C1E577BC7Q36439065-2B7B6F4F-E6EF-4C21-A6E8-2EFAB47C310EQ37381432-73BB1305-28E0-4B3E-95EE-088BDEDDB789Q37778640-8F7663BB-58AE-46BA-B1F9-1BE0830DF393Q37905141-FDD51E8F-E149-496E-9EB5-5647B6AC2301Q38052553-D839A50C-674E-40DA-BAAF-BAC6FDB3A67BQ38561363-CEA167CA-751B-4407-A130-15CEC70FE607Q38760080-6C0078E0-BC9A-4542-98DE-2AF0EB377DACQ38933875-BB37757D-B3E5-4BBD-8905-460792B7BF2BQ39835731-4AA8D206-3B2A-443B-9CFC-32C4BE65EF46Q39849744-C706FF85-C392-4DE0-9284-50041D4622F7Q41833169-324E72DA-26EA-464A-A295-5E30CC03BDB9Q42202245-61588B7C-9B23-4224-91F3-1ECE5816A650Q43254552-34F8573A-4169-4ACE-9DE5-D9444C0932BFQ43902934-0CE3E698-2B47-4721-99AC-54A79F1D0382Q53699787-BE2A862A-E464-4E9D-A261-394DD3A76F07
P2860
Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents
description
1982 nî lūn-bûn
@nan
1982 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@ast
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@en
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@nl
type
label
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@ast
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@en
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@nl
prefLabel
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@ast
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@en
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@nl
P2093
P2860
P356
P1476
Pharmacokinetics and tolerance ...... n water and lidocaine diluents
@en
P2093
J Konikoff
M Parsonnet
R E Weinfeld
P2860
P304
P356
10.1128/AAC.21.6.957
P407
P577
1982-06-01T00:00:00Z